-
1
المؤلفون: Nasimian, Ahmad, Al Ashiri, Lina, Ahmed, Mehreen, Duan, Hongzhi, Zhang, Xiaoyue, Rönnstrand, Lars, Kazi, Julhash U
المصدر: International Journal of Molecular Sciences StemTherapy: National Initiative on Stem Cells for Regenerative Therapy EpiHealth: Epidemiology for Health. 24(4)
مصطلحات موضوعية: Humans, Sorafenib/therapeutic use, Tyrosine Protein Kinase Inhibitors, Mutation, Protein Kinase Inhibitors/pharmacology, Leukemia, Myeloid, Acute/genetics, fms-Like Tyrosine Kinase 3/genetics, Drug Resistance, Neoplasm/genetics, Cell Line, Tumor, Medicin och hälsovetenskap, Medicinska och farmaceutiska grundvetenskaper, Farmakologi och toxikologi, Medical and Health Sciences, Basic Medicine, Pharmacology and Toxicology, Klinisk medicin, Hematologi, Clinical Medicine, Hematology
الوصول الحر: https://lup.lub.lu.se/record/840acd1e-c345-48b4-8a37-c167184d0b94Test
http://dx.doi.org/10.3390/ijms24043830Test -
2دورية أكاديمية
المساهمون: Hyunwook Kim, Beung-Chul Ahn, Jiyun Lee, Jii Bum Lee, Min-Hee Hong, Hye Ryun Kim, Byoung Chul Cho, Sun Min Lim, Kim, Hyun Wook
مصطلحات موضوعية: Aniline Compounds / therapeutic use, Carcinoma, Non-Small-Cell Lung* / drug therapy, Non-Small-Cell Lung* / genetics, Non-Small-Cell Lung* / pathology, ErbB Receptors / genetics, Humans, Lung Neoplasms* / drug therapy, Lung Neoplasms* / genetics, Lung Neoplasms* / pathology, Mutation / genetics, Protein Kinase Inhibitors / pharmacology, Lazertinib, Non-small cell lung cancer, Real-world data, T790M EGFR mutation
العلاقة: LUNG CANCER; J02174; OAK-2023-02241; OAK-2023-02242; OAK-2023-02243; OAK-2023-02244; OAK-2023-02245; OAK-2023-02246; https://ir.ymlib.yonsei.ac.kr/handle/22282913/195937Test; https://www.sciencedirect.com/science/article/pii/S0169500223007511Test; T202304087; LUNG CANCER, Vol.180 : 107213, 2023-06
الإتاحة: https://doi.org/10.1016/j.lungcan.2023.107213Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/195937Test
https://www.sciencedirect.com/science/article/pii/S0169500223007511Test -
3دورية أكاديمية
المساهمون: Seung Yeon Oh, You Won Lee, Eun Ji Lee, Jae Hwan Kim, YoungJoon Park, Seong Gu Heo, Mi Ra Yu, Min Hee Hong, John DaSilva, Christopher Daly, Byoung Chul Cho, Sun Min Lim, Mi Ran Yun, Lim, Sun Min
مصطلحات موضوعية: Carcinoma, Non-Small-Cell Lung* / drug therapy, Non-Small-Cell Lung* / genetics, Non-Small-Cell Lung* / pathology, Cell Line, Tumor, Drug Resistance, Neoplasm / genetics, ErbB Receptors, Humans, Immunoconjugates* / therapeutic use, Lung Neoplasms* / drug therapy, Lung Neoplasms* / genetics, Lung Neoplasms* / pathology, Mutation, Protein Kinase Inhibitors / pharmacology, Protein Kinase Inhibitors / therapeutic use, Proto-Oncogene Proteins c-met
العلاقة: CLINICAL CANCER RESEARCH; J00564; OAK-2023-01589; OAK-2023-01590; https://ir.ymlib.yonsei.ac.kr/handle/22282913/195372Test; https://aacrjournals.org/clincancerres/article/29/1/221/711969Test; T202303016; CLINICAL CANCER RESEARCH, Vol.29(1) : 221-232, 2023-01
الإتاحة: https://doi.org/10.1158/1078-0432.CCR-22-2180Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/195372Test
https://aacrjournals.org/clincancerres/article/29/1/221/711969Test -
4دورية أكاديمية
المساهمون: Christian Kollmannsberger, Herbert Hurwitz, Lyudmila Bazhenova, Byoung Chul Cho, David Hong, Keunchil Park, Karen L Reckamp, Sunil Sharma, Hirak Der-Torossian, James G Christensen, Demiana Faltaos, Diane Potvin, Vanessa Tassell, Richard Chao, Geoffrey I Shapiro, Cho, Byoung Chul
مصطلحات موضوعية: Antineoplastic Agents* / therapeutic use, Carcinoma, Non-Small-Cell Lung* / drug therapy, Non-Small-Cell Lung* / genetics, Humans, Lung Neoplasms* / drug therapy, Maximum Tolerated Dose, Neoplasms* / drug therapy, Protein Kinase Inhibitors / pharmacology, Protein Kinase Inhibitors / therapeutic use, Tablets
العلاقة: TARGETED ONCOLOGY; J03951; OAK-2023-01380; https://ir.ymlib.yonsei.ac.kr/handle/22282913/195299Test; https://link.springer.com/article/10.1007/s11523-022-00931-9Test; T202302903; TARGETED ONCOLOGY, Vol.18(1) : 105-118, 2023-01
الإتاحة: https://doi.org/10.1007/s11523-022-00931-9Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/195299Test -
5دورية أكاديمية
المساهمون: Juliann Chmielecki, Jhanelle E Gray, Ying Cheng, Yuichiro Ohe, Fumio Imamura, Byoung Chul Cho, Meng-Chih Lin, Margarita Majem, Riyaz Shah, Yuri Rukazenkov, Alexander Todd, Aleksandra Markovets, J Carl Barrett, Ryan J Hartmaier, Suresh S Ramalingam, Cho, Byoung Chul
مصطلحات موضوعية: Carcinoma, Non-Small-Cell Lung* / drug therapy, Non-Small-Cell Lung* / genetics, ErbB Receptors / genetics, Humans, Lung Neoplasms* / drug therapy, Lung Neoplasms* / genetics, Mutation, Protein Kinase Inhibitors / pharmacology, Protein Kinase Inhibitors / therapeutic use
العلاقة: NATURE COMMUNICATIONS; J02293; OAK-2023-01384; https://ir.ymlib.yonsei.ac.kr/handle/22282913/195303Test; T202302907; NATURE COMMUNICATIONS, Vol.14(1) : 1070, 2023-02
الإتاحة: https://doi.org/10.1038/s41467-023-35961-yTest
https://ir.ymlib.yonsei.ac.kr/handle/22282913/195303Test -
6دورية أكاديمية
المساهمون: Se Un Jeong, Hee Sang Hwang, Ja-Min Park, Sun Young Yoon, Su-Jin Shin, Heounjeong Go, Jae-Lyun Lee, Gowun Jeong, Yong Mee Cho, Shin, Su Jin
مصطلحات موضوعية: B7-H1 Antigen / metabolism, Carcinoma, Renal Cell* / drug therapy, Renal Cell* / genetics, Renal Cell* / pathology, Humans, Kidney Neoplasms* / drug therapy, Kidney Neoplasms* / genetics, Kidney Neoplasms* / metabolism, Protein Kinase Inhibitors / pharmacology, Protein Kinase Inhibitors / therapeutic use, Receptor Protein-Tyrosine Kinases / genetics, TOR Serine-Threonine Kinases / metabolism, Up-Regulation, Vascular Endothelial Growth Factor A / metabolism, B7-H1 antigen, Receptor protein-tyrosine kinases, Renal cell carcinoma, TOR serine-threonine kinases
وصف الملف: application/pdf
العلاقة: CANCER RESEARCH AND TREATMENT; J00453; OAK-2022-11163; https://ir.ymlib.yonsei.ac.kr/handle/22282913/193644Test; T202301274; CANCER RESEARCH AND TREATMENT, Vol.55(1) : 231-244, 2023-01
الإتاحة: https://doi.org/10.4143/crt.2021.1526Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/193644Test -
7دورية أكاديمية
المؤلفون: GUREGHIAN, Vincent, HERBST, Hailee, KOZAR, Ines, MIHAJLOVIC, Katarina, Malod-Dognin, Noël, Ceddia, Gaia, ANGELI, Cristian, WURTH-MARGUE, Christiane, RANDIC, Tijana, PHILIPPIDOU, Demetra, TETSI NOMIGNI, Milène, HEMEDAN, Ahmed, TRANCHEVENT, Leon-Charles, LONGWORTH, Joseph, Bauer, Mark, BADKAS, Apurva, GAIGNEAUX, Anthoula, Muller, Arnaud, OSTASZEWSKI, Marek, TOLLE, Fabrice, Pržulj, Nataša, KREIS, Stephanie
المصدر: Cancer Gene Therapy, 30 (10), 1330 - 1345 (2023-10)
مصطلحات موضوعية: Protein Kinase Inhibitors, Insulins, NRAS protein, human, Membrane Proteins, GTP Phosphohydrolases, Humans, Multiomics, Cell Line, Tumor, Protein Kinase Inhibitors/pharmacology, Protein Kinase Inhibitors/therapeutic use, Cellular Senescence/genetics, Membrane Proteins/genetics, GTP Phosphohydrolases/genetics, GTP Phosphohydrolases/therapeutic use, Melanoma/drug therapy, Melanoma/genetics, Insulins/therapeutic use, Cellular Senescence, Melanoma, Molecular Medicine, Molecular Biology, Cancer Research, Life sciences, Sciences du vivant
العلاقة: https://www.nature.com/articles/s41417-023-00640-z.pdfTest; urn:issn:0929-1903; urn:issn:1476-5500; https://orbilu.uni.lu/handle/10993/59253Test; info:hdl:10993/59253; https://orbilu.uni.lu/bitstream/10993/59253/1/Gureghian%20et%20al%20Cancer%20Gene%20Therapy%202023.pdfTest; scopus-id:2-s2.0-85164201373; info:pmid:37420093; wos:001020725100001
الإتاحة: https://doi.org/10.1038/s41417-023-00640-zTest
https://orbilu.uni.lu/handle/10993/59253Test
https://orbilu.uni.lu/bitstream/10993/59253/1/Gureghian%20et%20al%20Cancer%20Gene%20Therapy%202023.pdfTest -
8دورية أكاديمية
المؤلفون: RANDIC, Tijana, MAGNI, Stefano, PHILIPPIDOU, Demetra, Margue, Christiane, GRZYB, Kamil, PREIS, Jasmin Renate, WROBLEWSKA, Joanna Patrycja, NAZAROV, Petr, MITTELBRONN, Michel, FRAUENKNECHT, Katrin, SKUPIN, Alexander, KREIS, Stephanie
المصدر: Cell Reports, 42 (7), 112696 (2023-07-25)
مصطلحات موضوعية: CP: Cancer, MEK/CDK4/6 co-inhibition, NRAS-mutant melanoma, P2RX7, drug resistance, single-cell RNA-sequencing, Protein Kinase Inhibitors, Proto-Oncogene Proteins B-raf, P2RX7 protein, human, Receptors, Purinergic P2X7, NRAS protein, Membrane Proteins, GTP Phosphohydrolases, Humans, Protein Kinase Inhibitors/pharmacology, Neoplasm/genetics, Cell Line, Tumor, Mutation/genetics, Proto-Oncogene Proteins B-raf/genetics, Purinergic P2X7/metabolism, Membrane Proteins/metabolism, GTP Phosphohydrolases/genetics, GTP Phosphohydrolases/metabolism, Transcriptome, Melanoma/drug therapy, Melanoma/genetics, Melanoma/metabolism
العلاقة: https://api.elsevier.com/content/article/PII:S2211124723007076?httpAccept=text/xmlTest; urn:issn:2211-1247; https://orbilu.uni.lu/handle/10993/58082Test; info:hdl:10993/58082; https://orbilu.uni.lu/bitstream/10993/58082/1/Randic%20et%20al%2c%202023.pdfTest; scopus-id:2-s2.0-85163502753; info:pmid:37379213; wos:001030571600001
الإتاحة: https://doi.org/10.1016/j.celrep.2023.112696Test
https://orbilu.uni.lu/handle/10993/58082Test
https://orbilu.uni.lu/bitstream/10993/58082/1/Randic%20et%20al%2c%202023.pdfTest -
9دورية أكاديمية
المؤلفون: Anchisi, S., Wolfer, A., Bisig, B., Missiglia, E., Tiab, A., Kamel, E.M., Michielin, O., Coukos, G., Homicsko, K.
المصدر: Cancer biology & therapy, vol. 24, no. 1, pp. 2193116
مصطلحات موضوعية: Humans, Female, Proto-Oncogene Proteins B-raf/genetics, Melanoma/drug therapy, Melanoma/genetics, Melanoma/pathology, Protein Kinase Inhibitors/pharmacology, Protein Kinase Inhibitors/therapeutic use, Mitogen-Activated Protein Kinase Kinases, Ovarian Neoplasms/drug therapy, Ovarian Neoplasms/genetics, Mutation, BRAF, Ovarian cancer, adaptation, resistance
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36967525; info:eu-repo/semantics/altIdentifier/eissn/1555-8576; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_365141E36CC98; https://serval.unil.ch/notice/serval:BIB_365141E36CC9Test; urn:issn:1538-4047; https://serval.unil.ch/resource/serval:BIB_365141E36CC9.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_365141E36CC98Test
الإتاحة: https://doi.org/10.1080/15384047.2023.2193116Test
https://serval.unil.ch/notice/serval:BIB_365141E36CC9Test
https://serval.unil.ch/resource/serval:BIB_365141E36CC9.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_365141E36CC98Test -
10دورية أكاديمية
المؤلفون: Krebs, F.S., Moura, B., Missiaglia, E., Aedo-Lopez, V., Michielin, O., Tsantoulis, P., Bisig, B., Trimech, M., Zoete, V., Homicsko, K.
المصدر: International journal of molecular sciences, vol. 24, no. 5, pp. 4520
مصطلحات موضوعية: Male, Humans, Skin Neoplasms/genetics, Melanoma/genetics, Pyridones/therapeutic use, Pyrimidinones/therapeutic use, Protein Kinase Inhibitors/pharmacology, Mitogen-Activated Protein Kinase Kinases/genetics, Proto-Oncogene Proteins B-raf/genetics, Mutation, MAP Kinase Kinase 1/genetics, MAP2K1, cancer, modelling, triple-negative melanoma
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36901951; info:eu-repo/semantics/altIdentifier/eissn/1422-0067; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_E3A48A3138B74; https://serval.unil.ch/notice/serval:BIB_E3A48A3138B7Test; urn:issn:1422-0067; https://serval.unil.ch/resource/serval:BIB_E3A48A3138B7.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_E3A48A3138B74Test
الإتاحة: https://doi.org/10.3390/ijms24054520Test
https://serval.unil.ch/notice/serval:BIB_E3A48A3138B7Test
https://serval.unil.ch/resource/serval:BIB_E3A48A3138B7.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_E3A48A3138B74Test